Chemical class Small-molecule quinolinium compound Peptide status Not a peptide Primary research target Nicotinamide N-methyltransferase Common abbreviation 5A1MQ or 5-AMQ Evidence level Cell and animal research Human trials No controlled human trial identified UK approval No marketing authorisation identified Main evidence warning Mouse outcomes do not establish human results What Is 5-Amino-1MQ
MA1: $7,400, $7,400 MA2: $7,200 MA3: $7,500 MA4: $7,300, $7,300, $7,300 For example, the $7,400 MA1 charge from Step 1 was listed two times because there were two discharges for MS-DRG 123 that occurred during the cost report period ending September 30, 2026, for MA1
Otherwise stated, instead of helping your body run better, this NNMT pathway is quietly draining the tank
Dihexa CAS 1401708-83-5 White Solid Food Nutritional Supplement Specification Description Dihexa (developmental code name PNB-0408), also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, is an oligopeptide drug derived from angiotensin IV that binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at its receptor, c-Met
Used by many of our weight loss patients as a between-IV booster on a GLP-1 protocol
